
Ejenta provides an intelligent agent platform for connected care, leveraging AI technology licensed from NASA's Mission Control for the International Space Station. Their platform uses data from sensors and IoT devices to learn about users, detect abnormalities, and predict health deterioration. The intelligent agents interact with users to encourage healthy behavior and autonomously communicate with care teams. Ejenta's technology has been applied to healthcare, with a focus on remote patient monitoring and care delivery, partnering with organizations like Point32Health and being recognized for its work in space-related healthcare advancements.

Ejenta provides an intelligent agent platform for connected care, leveraging AI technology licensed from NASA's Mission Control for the International Space Station. Their platform uses data from sensors and IoT devices to learn about users, detect abnormalities, and predict health deterioration. The intelligent agents interact with users to encourage healthy behavior and autonomously communicate with care teams. Ejenta's technology has been applied to healthcare, with a focus on remote patient monitoring and care delivery, partnering with organizations like Point32Health and being recognized for its work in space-related healthcare advancements.
Product: AI-driven intelligent agent platform for remote health monitoring and care coordination
Tech origin: Platform built on NASA-licensed Brahms agent technology
Customers / partners: Deployments and pilots with health plans and collaborations with NASA/TRISH
Team size: About 5 employees (reported)
Funding: Recorded total funding $160,000 (most recent event Dec 17, 2020)
Remote patient monitoring, care coordination, and spaceflight health data management
2012
Healthcare technology
Most recent recorded funding event listed as Non-equity Assistance on Dec 17, 2020
“Investors reported include 500 Global, Yamaha Motor Ventures, Amazon Alexa Fund, MassChallenge and others”